Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Bruna R, Benedetti F, Boccomini C, Patti C, Barbui AM, Pulsoni A, Musso M, Liberati AM, Gini G, Castellino C, Rossini F, Ciceri F, Rota-Scalabrini D, Stelitano C, Di Raimondo F, Tucci A, Devizzi L, Zoli V, Zallio F, Narni F, Dondi A, Parvis G, Semenzato G, Lanza F, Perrone T, Angrilli F, Billio A, Gueli A, Mantoan B, Rambaldi A, Gianni AM, Corradini P, Passera R, Ladetto M, Tarella C.

Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.

2.

Colorimetric study about the stratification's effect on colour perception of resin composites.

La Rosa GRM, Pasquale S, Pedullà E, Palermo F, Rapisarda E, Gueli AM.

Odontology. 2019 Oct 29. doi: 10.1007/s10266-019-00469-9. [Epub ahead of print]

PMID:
31664633
3.

Cutting efficiency of conventional and heat-treated nickel-titanium rotary or reciprocating glide path instruments.

Pedullà E, Leanza G, La Rosa GRM, Gueli AM, Pasquale S, Plotino G, Rapisarda E.

Int Endod J. 2019 Sep 28. doi: 10.1111/iej.13224. [Epub ahead of print]

PMID:
31562824
4.

Safety Profile of the New Harmonic Focus: Different Emissivity and Temperature Behavior Between the Active and the Inactive Blade.

Latteri S, Stella G, Gueli AM, Mazzaglia S, Palumbo V, Guastella T.

Surg Laparosc Endosc Percutan Tech. 2019 Oct;29(5):e79-e83. doi: 10.1097/SLE.0000000000000712.

PMID:
31453911
5.

A new modified Mayo technique: should the surgeons need a new open technique for hernia repair in their armamentarium?

Toro A, Stella G, Gueli A, Mannino M, Teodoro M, Schembari E, Palermo F, Di Carlo I.

G Chir. 2018 Jul-Aug;39(4):208-214.

PMID:
30039787
6.

Dosimetric changes with computed tomography automatic tube-current modulation techniques.

Spampinato S, Gueli AM, Milone P, Raffaele LA.

Radiol Phys Technol. 2018 Jun;11(2):184-191. doi: 10.1007/s12194-018-0454-5. Epub 2018 Apr 6.

PMID:
29626289
7.

Characterization of phenolic pellets for ESR dosimetry in photon beam radiotherapy.

Gallo S, Iacoviello G, Panzeca S, Veronese I, Bartolotta A, Dondi D, Gueli AM, Loi G, Longo A, Mones E, Marrale M.

Radiat Environ Biophys. 2017 Nov;56(4):471-480. doi: 10.1007/s00411-017-0716-3. Epub 2017 Sep 19.

PMID:
28929295
8.

Influence of the X-ray beam quality on the dose increment in CT with iodinated contrast medium.

Amato E, Asero G, Leotta S, Auditore L, Salamone I, Mannino G, Privitera S, Gueli A.

J Xray Sci Technol. 2016;24(2):267-78. doi: 10.3233/XST-160551.

PMID:
27002906
9.

Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.

Balbo-Mussetto A, Cirillo S, Bruna R, Gueli A, Saviolo C, Petracchini M, Fornari A, Lario CV, Gottardi D, De Crescenzo A, Tarella C.

Clin Radiol. 2016 Mar;71(3):271-9. doi: 10.1016/j.crad.2015.11.018. Epub 2015 Dec 31.

PMID:
26749081
10.

Modified Mayo Technique for Ventral Hernia Repair: An Experimental Study.

Toro A, Stella G, Gueli A, Mannino M, Palermo F, Burrafato G, Di Carlo I.

Chirurgia (Bucur). 2015 Nov-Dec;110(6):545-9.

11.

Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival.

Tarella C, Gueli A, Delaini F, Rossi A, Barbui AM, Gritti G, Boschini C, Caracciolo D, Bruna R, Ruella M, Gottardi D, Passera R, Rambaldi A.

PLoS One. 2014 Sep 25;9(9):e106745. doi: 10.1371/journal.pone.0106745. eCollection 2014.

12.

Validation of the CT-MRI image registration with a dedicated phantom.

Spampinato S, Gueli AM, Raffaele L, Stancampiano C, Ettorre GC.

Radiol Med. 2014 Dec;119(12):942-950. doi: 10.1007/s11547-014-0392-1. Epub 2014 Jul 15.

PMID:
25024060
13.

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.

Magni M, Di Nicola M, Patti C, Scimè R, Mulè A, Rambaldi A, Intermesoli T, Viero P, Tarella C, Gueli A, Bergui L, Trentin L, Barzan A, Benedetti F, Ambrosetti A, Di Raimondo F, Chiarenza A, Parvis G, Billio A, Attolico I, Olivieri A, Montanari M, Carlo-Stella C, Matteucci P, Devizzi L, Guidetti A, Viviani S, Valagussa P, Gianni AM.

Bone Marrow Transplant. 2014 Apr;49(4):485-91. doi: 10.1038/bmt.2013.214. Epub 2014 Jan 20.

PMID:
24442244
14.

The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.

Rambaldi A, Boschini C, Gritti G, Delaini F, Oldani E, Rossi A, Barbui AM, Caracciolo D, Ladetto M, Gueli A, De Crescenzo A, Passera R, Devizzi L, Patti C, Gianni AM, Tarella C.

Am J Hematol. 2013 Dec;88(12):1062-7. doi: 10.1002/ajh.23566. Epub 2013 Sep 30.

15.

Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma.

Ferrero S, Monitillo L, Mantoan B, Barbero D, Genuardi E, Barbiero S, Bernocco E, Caracciolo D, Ruella M, Drandi D, Zanni M, Renna F, Lobetti Bodoni C, Gueli A, Passera R, Musto P, Boccadoro M, Tarella C, Ladetto M.

Ann Hematol. 2013 Nov;92(11):1503-11. doi: 10.1007/s00277-013-1797-y. Epub 2013 Jun 5.

PMID:
23737092
16.

Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.

Gueli A, Gottardi D, Hu H, Ricca I, De Crescenzo A, Tarella C.

Blood Transfus. 2013 Apr;11(2):311-4. doi: 10.2450/2012.0166-12. Epub 2013 Jan 22. No abstract available.

17.

Lymphocyte transformation and autoimmune disorders.

Tarella C, Gueli A, Ruella M, Cignetti A.

Autoimmun Rev. 2013 Jun;12(8):802-13. doi: 10.1016/j.autrev.2012.11.004. Epub 2012 Dec 4. Review.

PMID:
23219771
18.
19.

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma.

Tarella C, Passera R, Magni M, Benedetti F, Rossi A, Gueli A, Patti C, Parvis G, Ciceri F, Gallamini A, Cortelazzo S, Zoli V, Corradini P, Carobbio A, Mulé A, Bosa M, Barbui A, Di Nicola M, Sorio M, Caracciolo D, Gianni AM, Rambaldi A.

J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.

PMID:
21189387
20.

Children, parents and Respiratory Syncytial Virus in Palermo, Italy: prevention is primary.

Di Carlo P, Romano A, Plano MR, Gueli A, Scarlata F, Mammina C.

J Child Health Care. 2010 Dec;14(4):396-407. doi: 10.1177/1367493509359231. Epub 2010 Apr 15.

PMID:
20395316
21.

Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005-2006 in Palermo, Italy.

Di Carlo P, Romano A, Salsa L, Gueli A, Poma A, Fucà F, Dones P, Collura M, Pampinella D, Motisi D, Corsello G.

Ital J Pediatr. 2009 May 2;35(1):11. doi: 10.1186/1824-7288-35-11.

22.

An approach to 3D dose mapping using Gafchromic film.

Gueli AM, De Vincolis R, Kacperek A, Troja SO.

Radiat Prot Dosimetry. 2005;115(1-4):616-22.

PMID:
16381794
23.

2D and 3D dose distribution determination in proton beam radiotherapy with GafChromic film detectors.

Troja SO, Egger E, Francescon P, Gueli AM, Kacperek A, Coco M, Musmeci R, Pedalino A.

Technol Health Care. 2000;8(2):155-64.

PMID:
10955768

Supplemental Content

Support Center